UK Markets closed

Clinigen Group Plc (CLIN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
925.00+1.00 (+0.11%)
At close: 05:15PM BST
Full screen
Previous close924.00
Open924.00
Bid0.00 x 0
Ask0.00 x 0
Day's range924.00 - 925.00
52-week range9.25 - 948.05
Volume1,786,937
Avg. volume1,679,225
Market cap1.234B
Beta (5Y monthly)1.47
PE ratio (TTM)41.48
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.08 (0.82%)
Ex-dividend date02 Dec 2021
1y target estN/A
  • Reuters

    UK's Clinigen agrees to sweetened $1.8 billion Triton take-private deal

    Shareholders in Clinigen, whose top investor is hedge fund Elliott, will receive 925 pence per share in cash, up from a December bid of 883 pence apiece. New York-based Elliott, which had been raising its holding in Clinigen over the past few months amid reports it was seeking a break-up of the group, owns a 10.5% stake in the British company, according to Refintiv Eikon data. The latest offer by Triley Bidco, a newly created company indirectly owned by Triton Funds, is final and is recommended by the Clinigen board, the companies said in a joint statement.

  • Reuters

    UK pharmaceutical firm Clinigen agrees to $1.6 billion take-private deal

    Clinigen on Wednesday agreed to be bought by UK-based Triton Investment Management in a deal that values the pharmaceutical services group at about 1.2 billion pounds ($1.6 billion), making it the latest British company to go private. Last week, Clinigen confirmed advanced talks with the private-equity firm over a possible deal. Pressure has built on the company since Elliott Management raised its stake in recent weeks amid reports the activist investor was seeking to break up Clinigen.

  • Simply Wall St.

    Shareholders in Clinigen Group (LON:CLIN) are in the red if they invested three years ago

    In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...